Works matching IS 1619-7070 AND VI 45 AND IP 12 AND DT 2018

Results: 32

Advancing EJNMMI: continuing success and next developments.

Published in:

2018

By:

Carrió, Ignasi;
Chiti, Arturo

Publication type:

Editorial

Correction to: PET imaging of EGFR expression using an 18F-labeled RNA aptamer.

Published in:

2018

By:

Cheng, Siyuan;
Jacobson, Orit;
Zhu, Guizhi;
Chen, Zhen;
Liang, Steve H.;
Tian, Rui;
Yang, Zhen;
Niu, Gang;
Zhu, Xiaohua;
Chen, Xiaoyuan

Publication type:

Correction Notice

Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2201, doi. 10.1007/s00259-018-4116-y

By:

Stieb, Sonja;
Eleftheriou, Afroditi;
Warnock, Geoffrey;
Guckenberger, Matthias;
Riesterer, Oliver

Publication type:

Article

Correction to: Regulation of human brown adipose tissue by adenosine and A2A receptors - studies with [15O]H2O and [11C]TMSX PET/CT.

Published in:

2018

By:

Lahesmaa, Minna;
Oikonen, Vesa;
Helin, Semi;
Luoto, Pauliina;
U Din, Mueez;
Pfeifer, Alexander;
Nuutila, Pirjo;
Virtanen, Kirsi A.

Publication type:

Correction Notice

Quantification of myocardial blood flow with dynamic SPECT acquisitions: ready for prime time?

Published in:

2018

By:

Hyafil, Fabien;
Rouzet, François;
Le Guludec, Dominique

Publication type:

Editorial

Radiochemotherapy-induced reactivation of scar tissue on 18F-FDG PET/CT.

Published in:

2018

By:

Van Damme, Axel;
Duprez, Fréderic;
Tomassen, Peter;
Creytens, David;
Goethals, Ingeborg

Publication type:

Image

Delivering PET imaging results to cancer patients: steps for handling ethical issues.

Published in:

2018

By:

Gonzalez, Sandra;
Guedj, Eric;
Fanti, Stefano;
Lalumera, Elisabetta;
Le Coz, Pierre;
Taïeb, David

Publication type:

Letter to the Editor

Sodium-fluoride PET-CT for the non-invasive evaluation of coronary plaques in symptomatic patients with coronary artery disease: a cross-correlation study with intravascular ultrasound.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2181, doi. 10.1007/s00259-018-4122-0

By:

Li, Li;
Li, Xiang;
Jia, Yongping;
Fan, Jiamao;
Wang, Huifeng;
Fan, Chunyu;
Wu, Lei;
Si, Xincheng;
Hao, Xinzhong;
Wu, Ping;
Yan, Min;
Wang, Ruonan;
Hu, Guang;
Liu, Jianzhong;
Wu, Zhifang;
Hacker, Marcus;
Li, Sijin

Publication type:

Article

The SNMMI and EANM practice guideline for renal scintigraphy in adults.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2218, doi. 10.1007/s00259-018-4129-6

By:

Blaufox, M. Donald;
De Palma, Diego;
Taylor, Andrew;
Szabo, Zsolt;
Prigent, Alain;
Samal, Martin;
Li, Yi;
Santos, Andrea;
Testanera, Giorgio;
Tulchinsky, Mark

Publication type:

Article

90Y-radioembolization of hepatocellular carcinoma from a theranostic perspective: towards a personalized approach.

Published in:

2018

By:

Filippi, Luca;
Schillaci, Orazio;
Bagni, Oreste

Publication type:

Letter to the Editor

Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?

Published in:

2018

By:

Giovanella, Luca;
Avram, Anca M.;
Clerc, Jerome;
Hindié, Elif;
Taïeb, David;
Verburg, Frederik A.

Publication type:

Editorial

Could we avoid computing TMTV of DLBCL patients in routine practice?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2235, doi. 10.1007/s00259-018-4097-x

By:

Laffon, Eric;
Marthan, Roger

Publication type:

Article

Performance of 111In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2062, doi. 10.1007/s00259-018-4094-0

By:

Mix, Michael;
Reichel, Kathrin;
Stoykow, Christian;
Bartholomä, Mark;
Drendel, Vanessa;
Gourni, Eleni;
Wetterauer, Ulrich;
Schultze-Seemann, Wolfgang;
Meyer, Philipp T.;
Jilg, Cordula A.

Publication type:

Article

Prostate cancer imaging: when the game gets tough, the hard one gets done!

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2032, doi. 10.1007/s00259-018-4092-2

By:

Evangelista, Laura;
Sepulcri, Matteo;
Maruzzo, Marco

Publication type:

Article

Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2055, doi. 10.1007/s00259-018-4089-x

By:

Rahbar, Kambiz;
Afshar-Oromieh, Ali;
Seifert, Robert;
Wagner, Stefan;
Schäfers, Michael;
Bögemann, Martin;
Weckesser, Matthias

Publication type:

Article

Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis.

Published in:

2018

By:

Aide, Nicolas;
Salomon, Thibault;
Lasnon, Charline

Publication type:

Letter to the Editor

Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score.

Published in:

2018

By:

Peters, A. Michael;
Keramida, Georgia;
Pencharz, Deborah

Publication type:

Letter to the Editor

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo).

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2147, doi. 10.1007/s00259-018-4084-2

By:

Catalano, Onofrio A.;
Umutlu, Lale;
Fuin, Niccolo;
Hibert, Matthew Louis;
Scipioni, Michele;
Pedemonte, Stefano;
Vangel, Mark;
Catana, Andreea Maria;
Herrmann, Ken;
Nensa, Felix;
Groshar, David;
Mahmood, Umar;
Rosen, Bruce R.;
Catana, Ciprian

Publication type:

Article

Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2045, doi. 10.1007/s00259-018-4079-z

By:

Afshar-Oromieh, Ali;
Debus, Nils;
Uhrig, Monika;
Hope, Thomas A.;
Evans, Michael J.;
Holland-Letz, Tim;
Giesel, Frederik L.;
Kopka, Klaus;
Hadaschik, Boris;
Kratochwil, Clemens;
Haberkorn, Uwe

Publication type:

Article

18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2190, doi. 10.1007/s00259-018-4078-0

By:

Mckenney-Drake, Mikaela L.;
Moghbel, Mateen C.;
Paydary, Koosha;
Alloosh, Mouhamad;
Houshmand, Sina;
Moe, Sharon;
Salavati, Ali;
Sturek, Jeffrey M.;
Territo, Paul R.;
Weaver, Connie;
Werner, Thomas J.;
Høilund-Carlsen, Poul Flemming;
Sturek, Michael;
Alavi, Abass

Publication type:

Article

Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2139, doi. 10.1007/s00259-018-4077-1

By:

Lima, Giacomo Maria;
Matti, Antonella;
Vara, Giulio;
Dondi, Giulia;
Naselli, Nicoletta;
De Crescenzo, Eugenia Maria;
Morganti, Alessio Giuseppe;
Perrone, Anna Myriam;
De Iaco, Pierandrea;
Nanni, Cristina;
Fanti, Stefano

Publication type:

Article

Wael E. A. Saad: Portal hypertension. Imaging, diagnosis, and endovascular management. Third edition.

Published in:

2018

By:

Vultaggio, Viola;
Mansi, Luigi

Publication type:

Book Review

Martin Vahlensieck and Maximilian Reiser (Eds). MRI of the Musculoskeletal System, Second Edition.

Published in:

2018

By:

D'addio, Antonio;
Mansi, Luigi

Publication type:

Book Review

68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2035, doi. 10.1007/s00259-018-4067-3

By:

Caroli, Paola;
Sandler, Israel;
Matteucci, Federica;
De Giorgi, Ugo;
Uccelli, Licia;
Celli, Monica;
Foca, Flavia;
Barone, Domenico;
Romeo, Antonino;
Sarnelli, Anna;
Paganelli, Giovanni

Publication type:

Article

What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2122, doi. 10.1007/s00259-018-4065-5

By:

Bonomo, Pierluigi;
Merlotti, A.;
Olmetto, E.;
Bianchi, A.;
Desideri, I.;
Bacigalupo, A.;
Franco, P.;
Franzese, C.;
Orlandi, E.;
Livi, L.;
Caini, S.

Publication type:

Article

Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET/CT and posttreatment 90Y PET/CT in individualized dose prescription.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2110, doi. 10.1007/s00259-018-4064-6

By:

Ho, Chi Lai;
Chen, Sirong;
Cheung, Shing Kee;
Leung, Yim Lung;
Cheng, Kam Chau;
Wong, Ka Nin;
Wong, Yuet Hung;
Leung, Thomas Wai Tong

Publication type:

Article

[18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2159, doi. 10.1007/s00259-018-4045-9

By:

Rasul, Sazan;
Hartenbach, Sabrina;
Rebhan, Katharina;
Göllner, Adelina;
Karanikas, Georgios;
Mayerhoefer, Marius;
Mazal, Peter;
Hacker, Marcus;
Hartenbach, Markus

Publication type:

Article

Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2093, doi. 10.1007/s00259-018-4061-9

By:

Schaarschmidt, Benedikt Michael;
Grueneisen, Johannes;
Stebner, Vanessa;
Klode, Joachim;
Stoffels, Ingo;
Umutlu, Lale;
Schadendorf, Dirk;
Heusch, Philipp;
Antoch, Gerald;
Pöppel, Thorsten Dirk

Publication type:

Article

Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2079, doi. 10.1007/s00259-018-4059-3

By:

Pu, Yonglin;
Zhang, James X.;
Liu, Haiyan;
Appelbaum, Daniel;
Meng, Jianfeng;
Penney, Bill C.

Publication type:

Article

Feasibility of dynamic stress 201Tl/rest 99mTc-tetrofosmin single photon emission computed tomography for quantification of myocardial perfusion reserve in patients with stable coronary artery disease.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2173, doi. 10.1007/s00259-018-4057-5

By:

Han, Sangwon;
Kim, Young-Hak;
Ahn, Jung-Min;
Kang, Soo-Jin;
Oh, Jungsu S.;
Shin, Eonwoo;
Sung, Changhwan;
Chae, Sun Young;
Park, Seung-Jung;
Grimberg, Gillan;
Kovalski, Gil;
Moon, Dae Hyuk

Publication type:

Article

FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2071, doi. 10.1007/s00259-018-4056-6

By:

Incerti, E.;
Broggi, S.;
Fodor, A.;
Cuzzocrea, M.;
Samanes Gajate, A. M.;
Mapelli, P.;
Fiorino, C.;
Dell'oca, I.;
Pasetti, M.;
Cattaneo, M.;
Calandrino, R.;
Gianolli, L.;
Di Muzio, N.;
Picchio, Maria

Publication type:

Article

How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2103, doi. 10.1007/s00259-018-4063-7

By:

Roengvoraphoj, Olarn;
Eze, Chukwuka;
Wijaya, Cherylina;
Dantes, Maurice;
Taugner, Julian;
Tufman, Amanda;
Huber, Rudolf Maria;
Bartenstein, Peter;
Belka, Claus;
Manapov, Farkhad

Publication type:

Article

Works matching IS 1619-7070 AND VI 45 AND IP 12 AND DT 2018

Advancing EJNMMI: continuing success and next developments.

Correction to: PET imaging of EGFR expression using an <sup>18</sup>F-labeled RNA aptamer.

Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.

Correction to: Regulation of human brown adipose tissue by adenosine and A<sub>2A</sub> receptors - studies with [<sup>15</sup>O]H<sub>2</sub>O and [<sup>11</sup>C]TMSX PET/CT.

Quantification of myocardial blood flow with dynamic SPECT acquisitions: ready for prime time?

Radiochemotherapy-induced reactivation of scar tissue on <sup>18</sup>F-FDG PET/CT.

Delivering PET imaging results to cancer patients: steps for handling ethical issues.

Sodium-fluoride PET-CT for the non-invasive evaluation of coronary plaques in symptomatic patients with coronary artery disease: a cross-correlation study with intravascular ultrasound.

The SNMMI and EANM practice guideline for renal scintigraphy in adults.

<sup>90</sup>Y-radioembolization of hepatocellular carcinoma from a theranostic perspective: towards a personalized approach.

Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?

Could we avoid computing TMTV of DLBCL patients in routine practice?

Performance of <sup>111</sup>In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.

Prostate cancer imaging: when the game gets tough, the hard one gets done!

Diagnostic performance of <sup>18</sup>F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer.

Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis.

Assessment of alteration in liver <sup>18</sup>F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score.

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo).

Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer.

<sup>18</sup>F-NaF and <sup>18</sup>F-FDG as molecular probes in the evaluation of atherosclerosis.

Prognostic value of posttreatment <sup>18</sup>F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters.

Wael E. A. Saad: Portal hypertension. Imaging, diagnosis, and endovascular management. Third edition.

Martin Vahlensieck and Maximilian Reiser (Eds). MRI of the Musculoskeletal System, Second Edition.

<sup>68</sup>Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients.

What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis.

Radioembolization with <sup>90</sup>Y glass microspheres for hepatocellular carcinoma: significance of pretreatment <sup>11</sup>C-acetate and <sup>18</sup>F-FDG PET/CT and posttreatment <sup>90</sup>Y PET/CT in individualized dose prescription.

[<sup>18</sup>F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery.

Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?

Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging.

Feasibility of dynamic stress <sup>201</sup>Tl/rest <sup>99m</sup>Tc-tetrofosmin single photon emission computed tomography for quantification of myocardial perfusion reserve in patients with stable coronary artery disease.

FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients.

How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.